Alam Syed, MD
Radiation Oncology · Long Beach, CANPI 1316956279
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Reflexion Medical, Inc. at 39.4% of the total. Reporting peaked in 2021 at $415 and has fallen 62.4% since, to $156 in 2025.
Across 27 payments — averaging $33.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reflexion Medical, Inc.$357
- Novocure Inc.$131
- Johnson & Johnson$80
- Teleflex LLC$73
- Blue Earth Diagnostics$36
- AstraZeneca$36
- plus $192 from 10 others
Across 19 payments — averaging $2416.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Icad, Inc$44K
- Elekta, Inc.$2K
What the payments were for
- Food & beverage$905100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reflexion Medical, Inc. | 2 | $357 |
| Novocure Inc. | 6 | $131 |
| Johnson & Johnson | 4 | $80 |
| Teleflex LLC | 2 | $73 |
| Blue Earth Diagnostics | 1 | $36 |
| AstraZeneca | 2 | $36 |
| Siemens Medical Solutions USA, Inc. | 1 | $30 |
| Merck | 1 | $22 |
| Varian Medical Systems, Inc. | 1 | $22 |
| United Therapeutics Corporation | 1 | $19 |
| Accuray Incorporated | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Progenics Pharmaceuticals, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Sirtex Medical Inc | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$905 in reported general payments places this provider in the 60th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 12 | $397 |
| Tamsulosin Hcl | 13 | $169 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Long Beach
- Randy WeiLong Beach$9K
- Rakesh PatelLos Gatos$1.3M
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
- Arya AminiDuarte$265K
- Rizwan NuraniApple Valley$220K
- Drew MoghanakiLos Angeles$183K
- Jyoti MayadevSan Diego$170K
- Percy LeeIrvine$125K
- Felix FengSan Francisco$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.